Advertisement

New Approach in the Prevention of Atrial Fibrillation: Role of Angiotensin II Antagonists

  • P. Verdecchia
  • F. Angeli
  • M. G. Sardone
  • R. Gattobigio
Conference paper

Conclusions

Although lowering the blood pressure stands out as the fundamental mechanism for preventing any complication of hypertension, recent data suggest that ARBs might play an important and perhaps independent contribution in the prevention of AF. By inhibiting the effects of angiotensin II, ARBs reduce both blood pressure and myocardial fibrosis, with important potential implications for atrial and ventricular electric remodelling and atrial pressure and stretch. The LIFE study has shown the beneficial effect of losartan in reducing the risk of AF in hypertensive subjects in sinus rhythm. Further studies should clarify to what extent this effect applies to other ARBs.

Keywords

Atrial Fibrillation Framingham Heart Study Rheumatic Heart Disease Hypertensive Subject Chronic Atrial Fibrillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB, Abbott RD, Savage DD et al (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022PubMedCrossRefGoogle Scholar
  2. 2.
    Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461PubMedGoogle Scholar
  3. 3.
    Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedGoogle Scholar
  4. 4.
    Kannel WB, Wolf PA, Benjamin EJ et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRefGoogle Scholar
  5. 5.
    Ciaroni S, Cuenoud L, Bloch A (2000) Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J 139:814–819PubMedCrossRefGoogle Scholar
  6. 6.
    WB Kannel, RD Abbott, DD Savage et al (2002) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022CrossRefGoogle Scholar
  7. 7.
    Verdecchia P, Reboldi GP, Gattobigio R et al (2003) Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41:218–223PubMedCrossRefGoogle Scholar
  8. 8.
    Wyse DG, Gersh BJ (2004) Atrial fibrillation: a perspective thinking inside and outside the box. Circulation 109: 3089–3095PubMedCrossRefGoogle Scholar
  9. 9.
    Pedersen OD, Bagger H, Kober L et al (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100:376–380PubMedGoogle Scholar
  10. 10.
    Vermes E, Tardif JC, Bourassa MG et al (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107:2926–2931PubMedCrossRefGoogle Scholar
  11. 11.
    Madrid AH, Bueno MG, Rebollo JMG et al (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106:331–336PubMedCrossRefGoogle Scholar
  12. 12.
    Dahlöf B, Devereux RB, Kjeldsen SE for the LIFE study group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2005

Authors and Affiliations

  • P. Verdecchia
    • 1
  • F. Angeli
    • 1
  • M. G. Sardone
    • 1
  • R. Gattobigio
    • 1
  1. 1.Dipartimento Malattie CardiovascolariOspedale R. SilvestriniPerugiaItaly

Personalised recommendations